Medroxyprogesterone
Revision as of 20:39, 24 January 2024 by Rossdonaldson1 (talk | contribs) (Created page with "==Administration== *Type: *Dosage Forms: *Routes of Administration: *Common Trade Names: ==Adult Dosing== ===Non-pregnant vaginal bleeding=== *'''20 mg PO TID for 7 days'''<ref name="ACOG" /> **76% success, median time 3 days *Alternative, not officially endorsed by ACOG: 150mg IM x 1 then 20 mg PO TID x 3 days **In a trial of 48 patients all had cessation in 5 days.<ref name="highdose">Ammerman SR, Nelson AL. A new progestogen-only medical therapy for outpatient...")
Administration
- Type:
- Dosage Forms:
- Routes of Administration:
- Common Trade Names:
Adult Dosing
Non-pregnant vaginal bleeding
- 20 mg PO TID for 7 days[1]
- 76% success, median time 3 days
- Alternative, not officially endorsed by ACOG: 150mg IM x 1 then 20 mg PO TID x 3 days
- In a trial of 48 patients all had cessation in 5 days.[2]
- Contraindications
- History of VTE
- History of arterial thromboembolic events
- History of breast cancer
- Liver disease
Pediatric Dosing
Special Populations
Pregnancy Rating
Lactation risk
Renal Dosing
- Adult:
- Pediatric:
Hepatic Dosing
- Adult:
- Pediatric:
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion: